*	OR T1 T2
R1	Has_temporal Arg1:T4 Arg2:T3	
R2	Has_temporal Arg1:T4 Arg2:T1	
*	OR T4 T6 T7
R3	Has_qualifier Arg1:T10 Arg2:T11	
*	OR T8 T10
R4	Has_negation Arg1:T8 Arg2:T9	
R5	Has_negation Arg1:T10 Arg2:T9	
R6	AND Arg1:T4 Arg2:T8	
R7	Has_temporal Arg1:T14 Arg2:T15	
R8	Has_index Arg1:T16 Arg2:T17	
R9	Has_value Arg1:T22 Arg2:T21	
R10	Has_value Arg1:T20 Arg2:T19	
*	OR T20 T22
R11	AND Arg1:T18 Arg2:T20	
R12	AND Arg1:T14 Arg2:T18	
R13	Has_temporal Arg1:T14 Arg2:T16	
*	OR T25 T27
*	OR T32 T36 T35
*	OR T40 T41
R14	Has_value Arg1:T46 Arg2:T47	
R15	Has_temporal Arg1:T46 Arg2:T48	
R16	Has_value Arg1:T49 Arg2:T50	
R17	Has_index Arg1:T51 Arg2:T52	
*	OR T46 T49
R18	Has_temporal Arg1:T46 Arg2:T51	
R19	Has_temporal Arg1:T57 Arg2:T58	
R20	AND Arg1:T56 Arg2:T55	
R22	Has_index Arg1:T60 Arg2:T61	
*	OR T56 T57 T59
R21	Has_temporal Arg1:T59 Arg2:T58	
R23	Has_temporal Arg1:T54 Arg2:T60	
*	OR T64 T65
R24	Has_temporal Arg1:T64 Arg2:T63	
R25	Has_value Arg1:T64 Arg2:T67	
R26	Has_value Arg1:T68 Arg2:T69	
R27	Has_value Arg1:T72 Arg2:T73	
R28	Subsumes Arg1:T70 Arg2:T72	
R29	Has_index Arg1:T75 Arg2:T77	
*	OR T74 T75
R30	Has_index Arg1:T74 Arg2:T76	
R31	Has_temporal Arg1:T72 Arg2:T74	
R32	Has_multiplier Arg1:T87 Arg2:T86	
R33	Has_index Arg1:T89 Arg2:T90	
R34	Has_temporal Arg1:T87 Arg2:T89	
R35	Has_temporal Arg1:T56 Arg2:T60	
T1	Temporal 0 7	Current
T2	Temporal 11 18	chronic
T3	Temporal 19 26	history
T4	Condition 30 43	liver disease
T6	Condition 65 86	biliary abnormalities
T7	Condition 54 61;73 86	hepatic abnormalities
T8	Condition 110 128	Gilbert's syndrome
T9	Negation 97 106	exception
T10	Condition 145 155	gallstones
T11	Qualifier 132 144	asymptomatic
T14	Condition 170 197	regular alcohol consumption
T15	Temporal 159 166	History
T16	Temporal 198 226	within 6 months of the study
T17	Reference_point 217 226	the study
T18	Measurement 242 263	average weekly intake
T19	Value 267 276	>21 units
T20	Person 281 286	males
T21	Value 290 299	>14 units
T22	Person 304 311	females
T24	Parsing_Error 313 472	One unit is equivalent to 8 gram of alcohol: a half-pint (approximately 240 milliliter [mL]) of beer, 1 glass (100 mL) of wine or 1 (25 mL) measure of spirits.
T25	Condition 485 507	sensitivity to heparin
T26	Drug 500 507	heparin
T27	Condition 511 543	heparin-induced thrombocytopenia
T28	Qualifier 511 526	heparin-induced
T29	Drug 511 518	heparin
T30	Drug 583 600	study medications
T31	Context_Error 583 600	study medications
T32	Condition 557 600	sensitivity to any of the study medications
T33	Context_Error 557 600	sensitivity to any of the study medications
T34	Temporal 546 553	History
T35	Condition 640 644;654 661	drug allergy
T36	Condition 654 661	allergy
T37	Subjective_judgement 668 725	in the opinion of the investigator or GSK Medical Monitor
T38	Undefined_semantics 727 762	contraindicates their participation
T39	Subjective_judgement 727 762	contraindicates their participation
T40	Condition 765 789	Gastrointestinal disease
T41	Temporal 798 831	gastrointestinal surgical history
T42	Procedure 798 823	gastrointestinal surgical
T43	Qualifier 842 894	affect the absorption of the investigational product
T44	Context_Error 842 894	affect the absorption of the investigational product
T45	Undefined_semantics 842 894	affect the absorption of the investigational product
T46	Measurement 918 945	Hepatitis B surface antigen
T47	Value 899 907	positive
T48	Temporal 908 917	pre-study
T49	Measurement 958 978	Hepatitis C antibody
T50	Value 949 957	positive
T51	Temporal 986 1014	within 3 months of screening
T52	Reference_point 1005 1014	screening
T54	Grammar_Error 1024 1032	cotinine
T55	Measurement 1016 1039	Urinary cotinine levels
T56	Condition 1054 1061	smoking
T57	Condition 1076 1098	regular use of tobacco
T58	Temporal 1065 1072	history
T59	Condition 1076 1090;1103 1131	regular use of nicotine-containing products
T60	Temporal 1132 1166	within 6 months prior to screening
T61	Reference_point 1157 1166	screening
T63	Temporal 1180 1189	pre-study
T64	Measurement 1190 1194;1203 1209	drug screen
T65	Measurement 1195 1209	alcohol screen
T67	Value 1171 1179	positive
T68	Measurement 1232 1275	Human Immunodeficiency Virus (HIV) antibody
T69	Value 1214 1222	positive
T70	Condition 1278 1286	Pregnant
T71	Person 1287 1294	females
T72	Measurement 1321 1335	serum hCG test
T73	Value 1312 1320	positive
T74	Temporal 1336 1348	at screening
T75	Temporal 1352 1367	prior to dosing
T76	Reference_point 1339 1348	screening
T77	Reference_point 1361 1367	dosing
T79	Non-query-able 1370 1498	Where participation in the study would result in donation of blood or blood products in excess of 500 mL within a 90 day period.
T80	Undefined_semantics 1370 1498	Where participation in the study would result in donation of blood or blood products in excess of 500 mL within a 90 day period.
T81	Context_Error 1370 1498	Where participation in the study would result in donation of blood or blood products in excess of 500 mL within a 90 day period.
T82	Person 1510 1517	females
T83	Condition 1500 1509	Lactating
T84	Undefined_semantics 1520 1820	The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 90 days, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).
T85	Post-eligibility 1520 1820	The subject has participated in a clinical trial and has received an investigational product within the following time period prior to the first dosing day in the current study: 90 days, 5 half-lives or twice the duration of the biological effect of the investigational product (whichever is longer).
T86	Multiplier 1834 1848	more than four
T87	Drug 1849 1870	new chemical entities
T88	Undefined_semantics 1849 1870	new chemical entities
T89	Temporal 1871 1917	within 12 months prior to the first dosing day
T90	Reference_point 1897 1917	the first dosing day
